Empowering hope: Imaging Alzheimer's in the era of disease-modifying therapies | Symposium at RSNA 2025
2025-12-01
Tammie Benzinger, MD, PhD, Professor of Radiology and Neurological Surgery at Washington University in St. Louis, Chief of MRI at the Mallinckrodt Institute of Radiology, USA
Jana Ivanidze, MD, PhD, Associate Professor of Radiology, Weill Cornell Medical College, NY, USA
Suzie Bash, MD, Medical Director of Neuroradiology at RADNET at San Fernando Valley Interventional Radiology, USA
Jana Ivanidze, MD, PhD, Associate Professor of Radiology, Weill Cornell Medical College, NY, USA
Suzie Bash, MD, Medical Director of Neuroradiology at RADNET at San Fernando Valley Interventional Radiology, USA
Alzheimer’s disease is undergoing a paradigm shift - with disease-modifying therapies (DMTs) transforming care pathways and increasing the demand for precise, efficient imaging. This symposium explores how advanced imaging and technological innovations help clinicians meet these evolving diagnostic and operational requirements - supporting earlier diagnosis, standardized quantification, therapy monitoring, and streamlined workflows across care settings.